Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Site × Surgical Procedures, Operative × 30 days × Clear all

Sponsor

Conditions

Lung Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Neoplasms 2 Mouth Neoplasms 2 Glioblastoma 2 Colorectal Neoplasms 2 Brain Neoplasms 2 Wilms Tumor 1 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Sinonasal Squamous Cell Carcinoma 1 Sarcoma 1 Rectal Neoplasms 1 Pilonidal Sinus 1 Osteosarcoma 1 Oropharyngeal Neoplasms 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Melanoma 1 Liposarcoma 1 Leiomyosarcoma 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Hepatic Veno-Occlusive Disease 1 Head and Neck Neoplasms 1 HER2-positive Early Breast Cancer 1 Germinoma 1

Interventions

durvalumab 3 Fulvestrant 3 Carboplatin 3 pembrolizumab 2 Pemetrexed 2 Cisplatin 2 trametinib 1 ribociclib 1 pralsetinib 1 palbociclib 1 exemestane 1 darolutamide 1 dabrafenib 1 ceralasertib 1 STX-478 1 Radiosurgery 1 Paclitaxel 1 Letrozole 1 Immunotherapy 1 Gemcitabine 1 Cetuximab 1 Anastrozole 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡